How many institutions held GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q4 2025?

42 institutional investors reported GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q4 2025. Use the holders table for investor-level position and value details.

GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (GYRE)

Q: What does CUSIP 403783103 represent in this 13F holders report?

CUSIP 403783103 is the security identifier for GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 403783103

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 3,344,625
Total 13F value: $23,613,928
Share change: +248,570
SEC-reported price per share: $7.06
Number of holders: 42
Value change: +$1,729,612
Number of buys: 24
Number of sells: 13
Shares outstanding: 124,924,768

Security key

403783103

Report period

Q4 2025

Institutions

Top holders

GYRE full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Previous quarter: Q3 2025 GYRE THERAPEUTICS, INC. SEC filings GYRE THERAPEUTICS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 403783103

Newer quarter: Q2 2026 Previous quarter: Q3 2025

Recent filing periods:

Q3 2026 Q2 2026 Q3 2025

Ownership snapshot

Top reported holders of GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Songjiang Ma

Disclosed value leader

Songjiang Ma

Comparable rows

0/15

Latest evidence

30 Sep 2025

3/4/5 13F Highest disclosed value: $28,257,265 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Songjiang Ma has the largest disclosed position value at $28.26M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Songjiang Ma's linked filing trail.

Disclosed position value Top 5

Songjiang Ma $28.26M

VANGUARD GROUP INC $8.58M

BlackRock, Inc. $4.92M

GEODE CAPITAL MANAGEMENT, LLC $2.8M

STATE STREET CORP $1.36M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Songjiang Ma	3/4/5 President, Director 3/4/5	— mixed-class rows	$28,257,265 2,832,084 shares mixed-class rows	—	27 May 2025
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$8,583,170 1,150,559 shares	—	30 Sep 2025
BlackRock, Inc.	13F Company 13F	— denominator unverified	$4,919,101 659,397 shares	—	30 Sep 2025
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$2,795,243 374,620 shares	—	30 Sep 2025
STATE STREET CORP	13F Company 13F	— denominator unverified	$1,363,337 182,753 shares	—	30 Sep 2025
SBI Securities Co., Ltd.	13F Company 13F	— denominator unverified	$1,252,280 167,866 shares	—	30 Sep 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,344,625

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

-4

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 value	Q4 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend